A carregar...
Publicação
Engineered non-invasive functionalized dendrimer/dendron-entrapped/complexed gold nanoparticles as a novel class of theranostic (radio)pharmaceuticals in cancer therapy
| Nome: | Descrição: | Tamanho: | Formato: | |
|---|---|---|---|---|
| 18.68 MB | Adobe PDF |
Orientador(es)
Resumo(s)
Nanomedicine represents a very significant contribution in current cancer treatment; in addition to surgical
intervention, radiation and chemotherapeutic agents that unfortunately also kill healthy cells, inducing highly
deleterious and often life-threatening side effects in the patient. Of the numerous nanoparticles used against
cancer, gold nanoparticles had been developed for therapeutic applications. Inter alia, a large variety of den drimers, i.e. soft artificial macromolecules, have turned up as non-viral functional nanocarriers for entrapping
drugs, imaging agents, and targeting molecules. This review will provide insights into the design, synthesis,
functionalization, and development in biomedicine of engineered functionalized hybrid dendrimer-tangled gold
nanoparticles in the domain of cancer theranostic. Several aspects are highlighted and discussed such as 1)
dendrimer-entrapped gold(0) hybrid nanoparticles for the targeted imaging and treatment of cancer cells, 2)
dendrimer encapsulating gold(0) nanoparticles (Au DENPs) for the delivery of genes, 3) Au DENPs for drug
delivery applications, 4) dendrimer encapsulating gold radioactive nanoparticles for radiotherapy, and 5)
dendrimer/dendron-complexed gold(III) nanoparticles as technologies to take down cancer cells.
Descrição
Palavras-chave
Dendrimers Dendrons Gold(0)/(III) nanoparticles Gene and drug delivery Cancer therapy Theranostic strategy . Faculdade de Ciências Exatas e da Engenharia Centro de Química da Madeira
Contexto Educativo
Citação
Mignani, S., Shi, X., Ceña, V., Rodrigues, J., Tomas, H., & Majoral, J. P. (2021). Engineered non-invasive functionalized dendrimer/dendron-entrapped/complexed gold nanoparticles as a novel class of theranostic (radio) pharmaceuticals in cancer therapy. Journal of Controlled Release, 332, 346-366. https://doi.org/10.1016/j.jconrel.2021.03.003
Editora
Elsevier